Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Experimental Hematology

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.exphem.2017.12.012PMID 29305109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins.

  2017cited by this paper
• Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma.

  2016cited by this paper
• Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.

  2016cited by this paper
• Epigallocatechin-3-gallate suppresses alveolar epithelial cell apoptosis in seawater aspiration-induced acute lung injury via inhibiting STAT1-caspase-3/p21 associated pathway.

  2016cited by this paper
• Epigenetics in Multiple Myeloma.

  2016cited by this paper
• Patient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis.

  2016cited by this paper
• p21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β.

  2016cited by this paper
• Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis

  2014cited by this paper
• PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer.

  2014cited by this paper
• Differential Expression of STAT1 and p21 Proteins Predicts Pancreatic Cancer Progression and Prognosis

  2014cited by this paper
• Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

  2014cited by this paper
• The role of epigenetics in the biology of multiple myeloma

  2014cited by this paper
• Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

  2014cited by this paper
• Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

  2014cited by this paper
• Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors

  2013cited by this paper
• Scriptaid effects on breast cancer cell lines

  2012cited by this paper
• Latest advances and current challenges in the treatment of multiple myeloma

  2012cited by this paper
• Panobinostat for the treatment of multiple myeloma

  2012cited by this paper
• Multiple myeloma.

  2011cited by this paper
• Histone deacetylase inhibitors in cancer therapy.

  2009cited by this paper
• Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma

  2009cited by this paper
• Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.

  2009cited by this paper
• The genetics of the p53 pathway, apoptosis and cancer therapy

  2008cited by this paper
• Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer

  2008cited by this paper
• Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma

  2008cited by this paper
• Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.

  2008cited by this paper
• Cancer epigenomics: DNA methylomes and histone-modification maps

  2007cited by this paper
• A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.

  2006cited by this paper
• DNA methylation and histone modifications: teaming up to silence genes.

  2005cited by this paper
• Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.

  2005cited by this paper
• Progress in cancer chemoprevention: development of diet-derived chemopreventive agents.

  2000cited by this paper
• A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.

  2000cited by this paper
• p53 Induces Apoptosis by Caspase Activation through Mitochondrial Cytochrome c Release*

  2000cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper

• Scriptaid Improves Cashmere Goat Embryo Reprogramming by Affecting Donor Cell Pluripotency Molecule NANOG Expression

  2025cites this paper
• Understanding and Treating Epigenetic Drivers of Cancer

  2024cites this paper
• Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells

  2024cites this paper
• MetaHMEI: meta-learning for prediction of few-shot histone modifying enzyme inhibitors

  2023cites this paper
• Increased ATP2A1 Predicts Poor Prognosis in Patients With Colorectal Carcinoma

  2022cites this paper
• Anti-cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma Cells.

  2021cites this paper
• Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications

  2021cites this paper
• Design, Synthesis and Pharmacological Evaluation of Naphthofuran Derivatives as Potent SIRT1 Activators

  2021cites this paper
• Cadmium, Smoking, and Human Blood DNA Methylation Profiles in Adults from the Strong Heart Study

  2020cites this paper
• The circ_0021977/miR‐10b‐5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer

  2020cites this paper
• A short guide to histone deacetylases including recent progress on class II enzymes

  2020cites this paper
• Antitumor effect of lenalidomide in malignant glioma cell lines

  2020cites this paper
• Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma

  2020cites this paper
• Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma

  2020cites this paper
• Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma

  2020cites this paper
• Identification of key pathways and genes in colorectal cancer to predict the prognosis based on mRNA interaction network

  2019cites this paper
• An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs.

  2019cites this paper
• Epigenetic Regulation of p21cip1/waf1 in Human Cancer

  2019cites this paper
• Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP1 fragment

  2018cites this paper
• Anti-Proliferative Activity of HPOB against Multiple Myeloma Cells via p21 Transcriptional Activation

  2018cites this paper
• Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway

  2018cites this paper
• Identification of a novel c-Myc inhibitor with antitumor effects on multiple myeloma cells

  2018cites this paper
• The Detailed Comparison of Cell Death Detected by Annexin V-PI Counterstain Using Fluorescence Microscope, Flow Cytometry and Automated Cell Counter in Mammalian and Microalgae Cells

  2018cites this paper
• Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma

  2018cites this paper
• Wnt and BMP signaling pathways co‐operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2

  2018cites this paper
• Structural basis of the specific interaction of SMRT corepressor with histone deacetylase 4

  2018cites this paper